Penumbra upgraded to Overweight from Equal Weight at Wells Fargo

Wells Fargo analyst Larry Biegelsen upgraded Penumbra (PEN) to Overweight from Equal Weight with a price target of $275, up from $190. The analyst believes THUNDER will be a positive trial and Thunderbolt could reach the market in 2025, representing potential upside next year. Wells sees the early enrollment completion as an encouraging sign and says it likely reflects physician enthusiasm for Thunderbolt. It potential upside from Thunderbolt for the shares.